Campbell & Co. Investment Adviser »

Monte Rosa Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-09-30 $379k 51k 7.41

More positions owned by Campbell & Co. Investment Adviser

Wheaton Precious Metals Corp Common Stock (WPM)
Rio Tinto Adr (RIO)
Sprouts Farmers Market Common Stock (SFM)
PTC Common Stock (PTC)
Agnico Eagle Mines Common Stock (AEM)
OGE Energy Corp Common Stock (OGE)
Paychex Common Stock (PAYX)
CMS Energy Corp Common Stock (CMS)
Royal Gold Common Stock (RGLD)
Logitech International SA Common Stock (LOGI)
Franklin Resources Common Stock (BEN)
Meta Platforms Common Stock (META)
Graphic Packaging Holding Common Stock (GPK)
Kinder Morgan Common Stock (KMI)
Pan American Silver Corp Common Stock (PAAS)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Versant Venture Management
Baker Bros. Advisors
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
Aisling Capital Management
Alphabet
Geode Capital Management
Marshall Wace
State Street Corporation
Vestal Point Capital
Northern Trust

View all funds holding Monte Rosa Therapeutics